This test is recommended for:
The Anti-HAV IgG (Antibodies to Hepatitis A Virus IgG) Test measures IgG antibodies against the Hepatitis A virus (HAV) in the blood. These antibodies usually develop after a person has recovered from a Hepatitis A infection or has been vaccinated against the virus. Their presence generally indicates long-term immunity to Hepatitis A.
Healthcare providers commonly recommend this test to determine whether an individual is protected against Hepatitis A, especially before international travel, during outbreak investigations, or before vaccination. It may also be used to identify previous exposure to the virus in individuals without a known history of infection or immunization.
Furthermore, the Anti-HAV IgG Test helps distinguish past infection or immunity from a recent or active Hepatitis A infection. Unlike the Anti-HAV IgM Test, which indicates a recent infection, the IgG test primarily confirms previous exposure or successful vaccination. When interpreted alongside clinical history and other hepatitis tests, it provides valuable information for evaluating a person's immune status.
The Anti-HAV IgG Test detects IgG antibodies against the Hepatitis A virus. It helps determine whether you have immunity due to a previous infection or successful vaccination against Hepatitis A.
No. Fasting is generally not required for this blood test. However, always follow any specific instructions provided by your healthcare provider before sample collection.
A positive Anti-HAV IgG result usually indicates that you have developed immunity to Hepatitis A through a previous infection or vaccination. It does not indicate an active infection. If a recent Hepatitis A infection is suspected, your doctor may recommend an Anti-HAV IgM Test along with other clinical evaluations.